June 28th: World Hepatitis Day

Viral Hepatitis, a group of diseases known as hepatitis A, B, C, D, and E, impacts more than 325 million people worldwide causing about 1 million deaths annually. The outcomes of the disease may include acute and chronic liver disease, sometimes leading to severe symptoms, development of liver cancer or even death. Today we have vaccines for hepatitis’ types A and B. Treatment options are available for the other types of hepatitis, and their effectiveness relies heavily on the timely diagnosis of the disease.

Depending on the type, hepatitis can be transmitted through sharing needles, close contact, contaminated food and water and from mothers to newborns. This year’s theme is “Hepatitis-free future” focusing on prevention of the infection among mothers and newborns.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.